ACP
TMO icon

Argyle Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Argyle Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$313K Buy
637
+111
+21% +$60.2K 0.23% 118
2025
Q4 		$305K Sell
526
-139
-21% -$78.6K 0.22% 117
2025
Q3 		$322K Sell
665
-140
-17% -$65.2K 0.23% 120
2025
Q2 		$326K Buy
+805
New +$337K 0.27% 105

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Argyle Capital Partners's TMO Position: Q1 2026 in Review

Argyle Capital Partners increased its Thermo Fisher Scientific (TMO) stake by 21% in Q1 2026, buying an estimated $60.2K and bringing the position to 637 shares worth $313K. The position accounts for 0.23% of the portfolio, ranked #118.

Argyle Capital Partners first reported a position in TMO in Q2 2025 and has held it in 4 quarters since. The position peaked at $326K in Q2 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Argyle Capital Partners held 637 shares of Thermo Fisher Scientific worth $313K as of Q1 2026.
  • Argyle Capital Partners bought 111 Thermo Fisher Scientific shares in Q1 2026, an estimated $60.2K.
  • Thermo Fisher Scientific made up 0.23% of Argyle Capital Partners's portfolio in Q1 2026, its #118 holding.
  • Argyle Capital Partners first reported a position in Thermo Fisher Scientific in Q2 2025 and has held it in 4 quarters since.
  • Argyle Capital Partners's Thermo Fisher Scientific position peaked at $326K in Q2 2025.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Argyle Capital Partners's 13F filing for Q1 2026, filed 7 May 2026.